Pfizer, BioNTech Complete Submission To EMA For Omicron BA.4

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) said Friday that they have completed a submission to the European Medicines Agency or EMA for a booster dose of an Omicron BA.4/BA.5-adapted

Related Keywords

, Pfizer , Pfizer Inc , European Union , European Medicines Agency , Drug Administration , More Such Health News , Emergency Use Authorization , Iontech , Omplete , Submission , Micron , Adapted , Bivalent , Vaccine ,